Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Sildenafil in Severe Pulmonary Hypertension Secondary to Rheumatic Chronic Valvular Disease: A Double-Blinded Placebo Randomized Control Trial

NCT07462260 is registered in ClinicalTrials.gov with Sindh Institute of Cardiovascular Diseases as lead sponsor.

NCT NCT07462260
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07462260 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Sildenafil in Severe Pulmonary Hypertension Secondary to Rheumatic Chronic Valvular Disease: A Double-Blinded Placebo Randomized Control Trial
Lead sponsor
Sindh Institute of Cardiovascular Diseases
Phase
Phase 2/3
Overall status
Completed
Start date
August 1, 2025
Completion date
September 23, 2026
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary hypertension, rheumatic valvular heart disease